Center for Rare Neurological Diseases
5600 Oakbrook Parkway
Norcross, Georgia 30093
Norcross, Georgia 30093
We've found
7 trials
at this facility
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
Updated: 12/31/1969
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Spinal Muscular Atrophy Clinical Trial
Updated: 12/31/1969
Pre-Symptomatic Study of Intravenous AVXS-101 in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Rett Syndrome Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Ketamine for the Treatment of Rett Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 12/31/1969
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Patients With Developmental and/or Epileptic Encephalopathies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
A Multicenter, Open-label, Pilot Study of TAK-935 (OV935) in Participants With 15Q Duplication Syndrome or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Rett Syndrome Clinical Trial
Updated: 2/5/2018
Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin
Status: Enrolling,
Phase
II
Updated: 2/5/2018
Click here to add this to my saved trials